Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · November 08, 2023

Sotorasib Plus Panitumumab for Refractory Colorectal Cancer With Mutated KRAS G12C

The New England Journal of Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
N. Engl. J. Med 2023 Oct 22;[EPub Ahead of Print], MG Fakih, L Salvatore, T Esaki, DP Modest, DP Lopez-Bravo, J Taieb, MV Karamouzis, E Ruiz-Garcia, TW Kim, Y Kuboki, F Meriggi, D Cunningham, KH Yeh, E Chan, J Chao, Y Saportas, Q Tran, C Cremolini, F Pietrantonio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading